|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | (2006.01) |
| A61K 31/713 | (2006.01) | ||
| C12N 15/113 | (2010.01) | ||
| A61K 9/127 | (2006.01) | ||
| C12N 15/11 | (2006.01) |
| (11) | Patento numeris | 2395012 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11169865.0 |
| Europos patento paraiškos padavimo data | 2006-11-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 732964 P | 2005-11-02 | US | |
| 817933 P | 2006-06-30 | US |
| (72) |
MacLachan, Ian, CA
Judge, Adam, CA
|
| (73) |
Arbutus Biopharma Corporation,
25th Floor, 700 West Georgia Street, Vancouver BC V7Y 1B3,
CA
|
| (54) | Modified siRNA molecules and uses thereof |
| Modified siRNA molecules and uses thereof |